TherapeuticsMD, Inc. Cash, Period Increase (Decrease)
TherapeuticsMD, Inc. (TXMD) reported Cash, Period Increase (Decrease) of $21.23 million for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-09.
Discontinued › Notes
us-gaap:CashPeriodIncreaseDecrease · last filed 2019-08-09
- TherapeuticsMD, Inc. cash, period increase (decrease) for the quarter ending 2019-06-30 was $59.96M, a 27.48% increase year-over-year.
- TherapeuticsMD, Inc. cash, period increase (decrease) for the quarter ending 2019-03-31 was -$38.73M.
- TherapeuticsMD, Inc. cash, period increase (decrease) for the quarter ending 2018-12-31 was -$28.39M.
- TherapeuticsMD, Inc. cash, period increase (decrease) for the quarter ending 2018-09-30 was $35.61M, a 31.27% decline year-over-year.
- TherapeuticsMD, Inc. cash, period increase (decrease) for fiscal 2018 was $34.48M.
- TherapeuticsMD, Inc. cash, period increase (decrease) for fiscal 2017 was -$4.40M, a 106.58% decline from fiscal 2016.
- TherapeuticsMD, Inc. cash, period increase (decrease) for fiscal 2016 was $66.83M, a 400.78% increase from fiscal 2015.
- TherapeuticsMD, Inc. cash, period increase (decrease) for fiscal 2015 was $13.34M.
| Period end | Cash, Period Increase (Decrease) 3 month | Cash, Period Increase (Decrease) 6 month | Cash, Period Increase (Decrease) 6 month as first filed | Cash, Period Increase (Decrease) 9 month | Cash, Period Increase (Decrease) 9 month as first filed | Cash, Period Increase (Decrease) 12 month |
|---|---|---|---|---|---|---|
| 2019-06-30 | $59.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $21.23M 10-Q · filed 2019-08-09 | -$7.15M derived: sum of 3 quarters · filed 2019-08-09 | $28.46M derived: sum of 4 quarters · filed 2019-08-09 | ||
| 2019-03-31 | -$38.73M 10-Q · filed 2019-05-08 | -$67.12M derived: sum of 2 quarters · filed 2019-05-08 | -$31.50M derived: sum of 3 quarters · filed 2019-05-08 | $15.53M derived: sum of 4 quarters · filed 2019-08-09 | ||
| 2018-12-31 | -$28.39M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $7.23M derived: sum of 2 quarters · filed 2019-02-27 | $54.26M derived: sum of 3 quarters · filed 2019-08-09 | $34.48M 10-K · filed 2019-02-27 | ||
| 2018-09-30 | $35.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $82.65M derived: sum of 2 quarters · filed 2019-08-09 | $62.86M 10-Q · filed 2018-11-08 | $41.71M derived: sum of 4 quarters · filed 2019-08-09 | ||
| 2018-06-30 | $47.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $27.25M 10-Q · filed 2019-08-09 | $6.09M derived: sum of 3 quarters · filed 2019-08-09 | $57.91M derived: sum of 4 quarters · filed 2019-08-09 | ||
| 2018-03-31 | -$19.79M 10-Q · filed 2019-05-08 | -$40.94M derived: sum of 2 quarters · filed 2019-05-08 | $10.87M derived: sum of 3 quarters · filed 2019-05-08 | -$6.18M derived: sum of 4 quarters · filed 2019-05-08 | ||
| 2017-12-31 | -$21.16M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $30.66M derived: sum of 2 quarters · filed 2019-02-27 | $13.61M derived: sum of 3 quarters · filed 2019-02-27 | -$4.40M 10-K · filed 2019-02-27 | ||
| 2017-09-30 | $51.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $34.77M derived: sum of 2 quarters · filed 2018-11-08 | $16.76M 10-Q · filed 2018-11-08 | $758.59K derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2017-06-30 | -$17.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-30 | -$35.06M 10-Q · filed 2018-07-30 | -$51.06M derived: sum of 3 quarters · filed 2019-02-27 | -$70.06M derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2017-03-31 | -$18.01M 10-Q · filed 2018-05-07 | -$34.01M derived: sum of 2 quarters · filed 2019-02-27 | -$53.01M derived: sum of 3 quarters · filed 2019-02-27 | -$68.57M derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2016-12-31 | -$16.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -$35.00M derived: sum of 2 quarters · filed 2019-02-27 | -$50.56M derived: sum of 3 quarters · filed 2019-02-27 | $66.83M 10-K · filed 2019-02-27 | ||
| 2016-09-30 | -$19.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$34.56M derived: sum of 2 quarters · filed 2017-11-07 | $82.83M 10-Q · filed 2017-11-07 | $66.41M derived: sum of 4 quarters · filed 2018-02-23 | ||
| 2016-06-30 | -$15.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $101.83M 10-Q · filed 2017-08-03 | $85.41M derived: sum of 3 quarters · filed 2018-02-23 | $99.29M derived: sum of 4 quarters · filed 2018-02-23 | ||
| 2016-03-31 | $117.39M 10-Q · filed 2017-05-03 | $100.97M derived: sum of 2 quarters · filed 2018-02-23 | $114.85M derived: sum of 3 quarters · filed 2018-02-23 | $90.44M derived: sum of 4 quarters · filed 2018-02-23 | ||
| 2015-12-31 | -$16.42M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | -$2.54M derived: sum of 2 quarters · filed 2018-02-23 | -$26.95M derived: sum of 3 quarters · filed 2018-02-23 | $13.34M 10-K · filed 2018-02-23 | ||
| 2015-09-30 | $13.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | -$10.53M derived: sum of 2 quarters · filed 2016-11-04 | $29.76M 10-Q · filed 2016-11-04 | $14.12M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2015-06-30 | -$24.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $15.88M 10-Q · filed 2016-08-05 | $246.58K derived: sum of 3 quarters · filed 2017-02-28 | $31.69M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2015-03-31 | $40.30M 10-Q · filed 2016-05-05 | $24.66M derived: sum of 2 quarters · filed 2017-02-28 | $56.10M derived: sum of 3 quarters · filed 2017-02-28 | $46.25M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2014-12-31 | -$15.64M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $15.81M derived: sum of 2 quarters · filed 2017-02-28 | $5.96M derived: sum of 3 quarters · filed 2017-02-28 | -$2.83M 10-K · filed 2017-02-28 | ||
| 2014-09-30 | $31.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $21.59M derived: sum of 2 quarters · filed 2015-11-05 | $12.81M 10-Q · filed 2015-11-05 | $7.43M derived: sum of 4 quarters · filed 2016-02-26 | ||
| 2014-06-30 | -$9.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$18.64M 10-Q · filed 2015-08-07 | -$24.02M derived: sum of 3 quarters · filed 2016-02-26 | $1.12M derived: sum of 4 quarters · filed 2016-02-26 | ||
| 2014-03-31 | -$8.79M 10-Q · filed 2015-05-07 | -$14.17M derived: sum of 2 quarters · filed 2016-02-26 | $10.97M derived: sum of 3 quarters · filed 2016-02-26 | $6.62M derived: sum of 4 quarters · filed 2016-02-26 | ||
| 2013-12-31 | -$5.38M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $19.76M derived: sum of 2 quarters · filed 2016-02-26 | $15.41M derived: sum of 3 quarters · filed 2016-02-26 | $52.64M 10-K · filed 2016-02-26 | ||
| 2013-09-30 | $25.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $20.79M derived: sum of 2 quarters · filed 2014-11-07 | $58.02M 10-Q · filed 2014-11-07 | $59.42M derived: sum of 4 quarters · filed 2015-03-12 | ||
| 2013-06-30 | -$4.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $32.88M 10-Q · filed 2014-08-07 | $34.28M derived: sum of 3 quarters · filed 2015-03-12 | $33.11M derived: sum of 4 quarters · filed 2015-03-12 | ||
| 2013-03-31 | $37.23M 10-Q · filed 2014-05-07 | $38.63M derived: sum of 2 quarters · filed 2015-03-12 | $37.45M derived: sum of 3 quarters · filed 2015-03-12 | $38.58M derived: sum of 4 quarters · filed 2015-03-12 | ||
| 2012-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $226.46K derived: sum of 2 quarters · filed 2015-03-12 | $1.36M derived: sum of 3 quarters · filed 2015-03-12 | $1.43M 10-K · filed 2015-03-12 | ||
| 2012-09-30 | -$1.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | -$40.92K derived: sum of 2 quarters · filed 2013-11-05 | $27.83K 10-Q · filed 2013-11-05 | $303.00 derived: sum of 4 quarters · filed 2014-03-05 | ||
| 2012-06-30 | $1.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $1.20M 10-Q · filed 2013-08-07 | $1.17M derived: sum of 3 quarters · filed 2014-03-05 | $1.25M derived: sum of 4 quarters · filed 2014-03-05 | ||
| 2012-03-31 | $68.75K 10-Q · filed 2013-05-10 | $41.23K derived: sum of 2 quarters · filed 2014-03-05 | $116.91K derived: sum of 3 quarters · filed 2014-03-05 | $176.64K derived: sum of 4 quarters · filed 2014-03-05 | ||
| 2011-12-31 | -$27.52K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-05 | $48.17K derived: sum of 2 quarters · filed 2014-03-05 | $107.89K derived: sum of 3 quarters · filed 2014-03-05 | -$296.52K 10-K · filed 2014-03-05 | ||
| 2011-09-30 | $75.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | $135.41K derived: sum of 2 quarters · filed 2012-11-13 | -$269.00K 10-Q · filed 2012-11-13 | $2.99K 10-Q · filed 2011-11-07 | ||
| 2011-06-30 | $59.72K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$344.68K 10-Q · filed 2012-08-09 | $2.21K 10-Q · filed 2011-08-15 | |||
| 2011-03-31 | -$404.41K 10-Q · filed 2012-05-11 | |||||
| 2010-09-30 | $20.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | $23.78K 10-Q · filed 2011-11-07 | ||||
| 2010-06-30 | $3.51K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |